|
|
|
Real Estate News Releases
|
(EMAILWIRE.COM, March 01, 2012 ) Belize City, Belize -- Publishers of daily newsletter xtremepicks.com (http://www.xtremepicks.com) looks Cannabis Science (CBIS):
When investors have a trifecta indicator of a “Golden Cross”, “Blue Sky” Territory, and “Flag Bullish Breakout” they have a recipe for a mega breakout just like xtremepicks have seen with Cannabis Science (CBIS) yesterday.
Members are now up 300%+ since xtremepicks alert last month
Xtremepicks alerted members a few weeks back at $0.04 of this monster and CBIS never looked back closing today up 57.41% and 332% since their alert!
http://www.cannabisscience.com/templates/rt_metamorph_j15/images/blank.gif
CBIS technical chart is showing all the classic signs of a bullish breakout and potential 1,000% gains in the making. Recent news by the company is definitely hinting to a monster press release yet to come which can really get this going.
Direct Global Media will also be issuing a Special Research Report on Cannabis Science (CBIS) – Revolutionizing the Medical Industry. Stay tuned for the release this weekend.
CBIS closed at $0.173 up 57.41% on a record breaking volume of 100 Million shares. Now in blue sky territory, itÂ’s anyoneÂ’s guess how HIGH this will go especially with anticipated monster news just around the corner.
CBIS Chart
CBIS series of press releases over the past month is definitely building towards a monster release – a worthy read and recap:
Headlines
Cancer Drug Market Evolves – Cannabis Science and ARIAD Pharmaceuticals Poised to BenefitMarketwire(Mon Feb 27)
Cannabis Science Chief Operating Officer Dr. Moe Afaneh, Pharm D., MBA, NRCC, Confirms Newest Cannabis Science Brand Product Line & Begins Manufacturing and National Distribution Negotiations to Immediately Release The New Product LineBusiness Wire(Fri Feb 24)
Cannabis Science Presents Newest Case Photos of the 3rd Critical Squamous Cell Carcinoma Self-Medicated Cannabis Patient with Clear Continued ImprovementBusiness Wire(Thu Feb 23)
A&E Begins Filming An 8-episode Documentary With Cannabis ScienceÂ’s Newly Appointed Director of Horticulture Bret Bogue; Focused On Bret Bogue, World Renowned Medical Cannabis CultivatorBusiness Wire(Wed Feb 22)
Cannabis Science Appoints Former Walgreens Executive Pharmacist Dr. Moe Afaneh, Pharm D., MBA, NRCC, RNC as Chief Operating Officer (COO) To Immediately Bring the Cannabis Science Brand of Products to the National MarketBusiness Wire(Thu Feb 16)
Cannabis Science Signs Multi-Company Acquisition & Licensing Deals that will Boost Revenues, Its Pharmaceutical Operations and Management Team While Bringing Cannabis Science Brand Products For National DistributionBusiness Wire(Tue Feb 14)
Cannabis Science Awaits Full Biopsy Report As Newest Series of Photos Shows Cancer Lesion Evidently Completely Killed & Hair Re-growth Begins On New Healthy Skin From 2nd Self-Administering Cancer PatientBusiness Wire(Tue Feb 7)
Cannabis Science Issues Corporate & Operations Guidance to Shareholders in Regards to Dividend, Market Potential, and Anecdotal ReportsBusiness Wire(Thu Feb 2)
Cannabis Science Reports Success For 4th Brand New Self-Administering Cancer PatientBusiness Wire(Thu Feb 2)
FDA Fast-Tracks New Cancer Drug for Skin Cancer While Cannabis Science Offers Topical Treatment for Basal Cell Carcinoma with No Apparent Side EffectsBusiness Wire(Wed Feb 1)
About Cannabis Science, Inc.
Cannabis Science, Inc. is at the forefront of pharmaceutical grade medical marijuana research and development. The second formulations will address the needs of patients choosing to use concentrated cannabis extracts to treat their ailments. Eventually, all Americans will have access to a safe and effective FDA approved medicine regardless of which state they live in. To maintain that marijuana is a dangerous, addictive drug with no medical value is scientifically absurd. Cannabis medicines, with no effective lethal dose, are far safer than aspirin, acetaminophen, and most other OTC drugs that kill thousands of Americans every year.
The Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce and commercialize phytocannabinoid-based pharmaceutical products. In sum, we are dedicated to the creation of cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance.
About Xtremepicks.com
Xtremepicks.com team of excellence strives to find undervalued, good momentum stock plays. Xtremepicks.com provide market awareness services for small to mid-cap stocks with daily and special newsletters to keep you informed of the latest movers.
Xtremepicks.com penny stock newsletter is your trading connection and remember to always do your own research, use stop loss orders to protect yourself, and book your profits when in a position to do so.
Xtremepicks.com penny stock newsletter profiles are not a solicitation or recommendation to buy, sell or hold securities and is not offering securities for sale. Verify all claims and do your own due diligence. . Xtremepicks received no compensation for CBIS and may be buyers in the open market. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved
Directglobalmedia.com
Max Gordon
6479227508
contact@directglobalmedia.com 
|
|
|
|
Real Estate News by Sector
|
|
|
|
|
